AN EXAMINATION OF A POSSIBLE PHARMACOKINETIC INTERACTION BETWEEN NIFEDIPINE AND ANTIPYRINE

被引:6
作者
EDEKI, T [1 ]
JOHNSTON, A [1 ]
TURNER, P [1 ]
机构
[1] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
关键词
antipyrine; interaction; Nifedipine;
D O I
10.1007/BF00315420
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of 2 weeks oral intake of nifedipine (2×20 mg) on the oxidative metabolism of antipyrine was investigated in 12 normal volunteers, who had 1050 mg antipyrine solution orally before and after the course of nifedipine. There were no statistically significant differences in the saliva pharmacokinetic parameters of antipyrine on both occasions. However, the metabolite profile of antipyrine in urine showed a significant reduction in the amount of norantipyrine excreted after compared to that before nifedipine administration (16.5 vs 19.6%). This may have implications for drugs that share a similar demethylation pathway with norantipyrine. © 1990 Springer-Verlag.
引用
收藏
页码:405 / 407
页数:3
相关论文
共 24 条
  • [1] CHANGES IN ANTIPYRINE AND INDOCYANINE GREEN KINETICS DURING NIFEDIPINE, VERAPAMIL, AND DILTIAZEM THERAPY
    BAUER, LA
    STENWALL, M
    HORN, JR
    DAVIS, R
    OPHEIM, K
    GREENE, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) : 239 - 242
  • [2] COMPARISON OF THE INVIVO AND INVITRO RATES OF FORMATION OF THE 3 MAIN OXIDATIVE METABOLITES OF ANTIPYRINE IN MAN
    BOOBIS, AR
    BRODIE, MJ
    KAHN, GC
    TOVERUD, EL
    BLAIR, IA
    MURRAY, S
    DAVIES, DS
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) : 771 - 777
  • [3] BREIMER DD, 1984, PHARMACOKINETICS MOD
  • [4] DILTIAZEM TREATMENT IMPAIRS HEPATIC DRUG OXIDATION - STUDIES OF ANTIPYRINE
    CARRUM, G
    EGAN, JM
    ABERNETHY, DR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) : 140 - 143
  • [5] A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL OF NIFEDIPINE IN THE TREATMENT OF PRIMARY RAYNAUDS-PHENOMENON
    CORBIN, DOC
    WOOD, DA
    MACINTYRE, CCA
    HOUSLEY, E
    [J]. EUROPEAN HEART JOURNAL, 1986, 7 (02) : 165 - 170
  • [6] THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM
    DAHLQVIST, R
    BERTILSSON, L
    BIRKETT, DJ
    EICHELBAUM, M
    SAWE, J
    SJOQVIST, F
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) : 815 - 821
  • [7] DICKINSON TH, 1987, CLIN PHARMACOL THER, V41, P165
  • [8] EFFECT OF ORAL-ADMINISTRATION OF A NEW CALCIUM-CHANNEL BLOCKING-AGENT, BEPRIDIL ON ANTIPYRINE CLEARANCE IN MAN
    FUNCKBRENTANO, C
    CHAFFIN, PL
    WILKINSON, GR
    MCALLISTER, B
    WOOSLEY, RL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (04) : 559 - 560
  • [9] NIFEDIPINE IN UNSTABLE ANGINA - A DOUBLE-BLIND, RANDOMIZED TRIAL
    GERSTENBLITH, G
    OUYANG, P
    ACHUFF, SC
    BULKLEY, BH
    BECKER, LC
    MELLITS, ED
    BAUGHMAN, KL
    WEISS, JL
    FLAHERTY, JT
    KALLMAN, CH
    LLEWELLYN, M
    WEISFELDT, ML
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (15) : 885 - 889
  • [10] GINSBURG R, 1982, AM HEART J, V103, P44, DOI 10.1016/0002-8703(82)90527-0